Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood

Aging Male

Volumn 12, Issue 4, 2009, Pages 113-118

  Jockenhövel, Friedrich ^a   Minnemann, Timo ^b   Schubert, Markus ^b   Freude, Susanne ^b   Hübler, Doris ^d   Schumann, Christina ^b   Christoph, Arnd ^b   Gooren, Louis ^c   Ernst, Michael ^d  

^a Evangelisches Krankenhaus Herne   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d BAYER PHARMA AG   (Germany)

Author keywords

Effects; Testosterone; Time

Indexed keywords

JENAPHARM; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ADULT; AGED; AGGRESSIVENESS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EJACULATION; FATIGUE; HUMAN; HYPOGONADISM; MALE; MOOD; PENIS ERECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL SATISFACTION;

EID: 72949085547     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685530903322858     Document Type: Article

References (21)

1. Nieschlag E. Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol (Oxf) 2006;65:275-281.
2. Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M, Jockenhel F, Behre HM, Gooren L, Nieschlag E. More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate. Asian J Androl 2007;9:291-297.
3. Schubert M, Minnemann T, Hubler D, Rouskova D, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhovel F. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab 2004;89:5429-5434.
4. Behre HM, Abshagen K, Oettel M, Hubler D, Nieschlag E. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. Eur J Endocrinol 1999;140:414-419.
5. Behre HM, Nashan D, Hubert W, Nieschlag E. Depot gonadotropin-releasing hormone agonist blunts the androgeninduced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 1992;74:84-90.
6. Zerssen von D, Die Beschwerden-Liste. Weinheim, Germany: Beltz; 1976.
7. Jahnke W, Debus G. Die Eigenschaftsworterliste EWL. Eine mehrdimensionale Methode zur Beschreibung von Aspekten des Befindens. Goettingen, Germany: Hogrefe; 1978.
8. Hauptmann M, Wellmann J, Lubin JH, Rosenberg PS, Kreienbrock L. Analysis of exposure-time-response relationships using a spline weight function. Biometrics 2000;56:1105-1108.
9. Bancroft J. Hormones and human sexual behavior. J Sex Marital Ther 1984;10:3-21.
10. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 2005;186:411-427.
11. Bancroft J, Wu FC. Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 1983;12:59-66.
12. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006;3:382-404; discussion 404-407.
13. Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007;52:54-70.
14. Greenstein A, Mabjeesh NJ, Sofer M, Kaver I, Matzkin H, Chen J. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol 2005;173:530-532.
15. Yassin AA, Saad F. Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido). World J Urol 2006;24:639-644.
16. Yassin AA, Saad F, Diede HE. Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: results from an open-label uncontrolled study. Andrologia 2006;38:61-68.
17. Bancroft J. Biological factors in human sexuality. J Sex Res 2002;39:15-21.
18. Gooren LJ, Kruijver FP. Androgens and male behavior. Mol Cell Endocrinol 2002;198:31-40.
19. O'Connor DB, Archer J, Wu FC. Effects of testosterone on mood, aggression, and sexual behavior in young men: A double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab 2004;89:2837-2845.
20. Pope HG, Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Arch Gen Psychiatry 2000;57:133-140; discussion 155-156.
21. Zitzmann M. Effects of testosterone replacement and its pharmacogenetics on physical performance and metabolism. Asian J Androl 2008;10:364-372.